[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369312-105":59,"doc-detail-369312-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","low-frequency-of-structured-documentation-for-cancer-genetic-testing-in-a-large-electronic-health-record-dataset-a-brief-report-using-all-of-us-research-data","Low frequency of structured documentation for cancer genetic testing in a large electronic health record dataset - A brief report using All of Us Research data","","Annually, over two million people in the United States are diagnosed with cancer, with 10–20% linked to hereditary cancer syndromes. Genetic testing for pathogenic variants is standard care, yet access and completion remain limited. Using All of Us Research data covering more than one million Americans, the study assessed documentation of cancer genetic testing in electronic health records for patients with selected cancers. Among 60,135 eligible individuals, 73% reported family history, but only 281 had codes for a genetic test; 82% completed testing after diagnosis. While All of Us supports large-scale research, reporting structures complicate interpretation. Standardized documentation and shared data elements are essential to improve genetic testing uptake research and address gaps in care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/low-frequency-of-structured-documentation-for-cancer-genetic-testing-in-a-large-electronic-health-record-dataset-a-brief-report-using-all-of-us-research-data/369312/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/low-frequency-of-structured-documentation-for-cancer-genetic-testing-in-a-large-electronic-health-record-dataset-a-brief-report-using-all-of-us-research-data/369312.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study?","Question",{"text":112,"@type":113},"The study aimed to understand the rates and factors associated with completion of cancer genetic testing among individuals with cancer using All of Us Research data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were eligible participants selected?",{"text":117,"@type":113},"Participants diagnosed with breast, ovarian, colon, endometrial, or pancreatic cancer were selected using the All of Us Workbench cohort builder tool.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about documentation and test completion?",{"text":121,"@type":113},"Of 60,135 individuals with eligible cancer diagnostic codes, over 73% reported a family history of cancer, but only 281 had diagnosis or procedural codes for a cancer genetic test, and 82% completed the test after the cancer diagnosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369312,1790535818,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","DOI: 10. 1002/jgc4 .2011  \nB RI E F RE P O RT  \nLow frequency of structured documentation for cancer genetic testing in a large electronic health record dataset: A brief report using All of Us Research data  \nMeghan L. Underhill1  | Xintong Li2 | Jaimin Shah2 | Caitlin Dreisbach1,2  \n1School of Nursing, University of Rochester, Rochester, New York, USA 2Goregen Institute for Data Science, University of Rochester, Rochester, New York, USA  \nCorrespondence  \nMeghan L. Underhill, School of Nursing, University of Rochester, Rochester, NY, USA.  \nEmail: meghan_underhill@urmc. rochester. edu  \nFunding information  \nUniversity of Rochester, School of Nursing  \nAbstract  \nAnnually, over two million individuals in the United States are diagnosed with cancer, with 10–20% attributed to hereditary cancer syndromes. Genetic testing for pathogenic variants is a standard component of cancer care guided by tumor pathology and family history. Despite this, access to and completion of cancer genetic testing remains suboptimal. This study aims to understand the rates and factors associated with genetic testing completion among individuals with cancer. Utilizing data from the All of Us Research Program, which includes over one million Americans, we examined the documentation of genetic testing in electronic health records. Participants diagnosed with breast, ovarian, colon, endometrial, or pancreatic cancer were selected using the All of Us Workbench cohort builder tool. Descriptive and univariate analyses were conducted within the integrated Jupyter Notebook. Out of 60,135 individuals with a diagnostic code for the eligible cancers, over 73% reported a family history of cancer. However, only 281 individuals had a diagnosis or procedural code for a cancer genetic test, with 82% completing the test post-cancer diagnosis. While the All of Us data is a robust resource for large-scale research, challenges in data acquisition and interpretation arise due to the reporting structure of genetic findings in most data sources, such as electronic health records. To effectively utilize large-scale data for addressing issues in cancer genetic testing, shared data elements and standardized documentation are essential.  \nK E Y WO R D S  \ncancer genetics, electronic health record, public health  \n1 | INTRODUCTION  \nCancer is the second leading cause of death in the United States and approximately two million Americans are diagnosed annually (Siegel et al. , 2020) . Approximately 20% of all cancers are thought to be caused by an inherited pathogenic variant in a gene  \nassociated with cancer (Manchanda et al. , 2020) and an additional 20% of cancers are familial in nature (Hemminki et al. , 2023) . The criteria for eligibility for cancer genetic testing is expanding rapidly to include more and more individuals each year, as an example when pancreatic cancer was added in 2020 and the expansion of eligibility of people with breast cancer. Eligibility for genetic  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2025 The Author(s) . Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.  \nJ Genet Couns. 2025;34:e2011 .  \n[https://doi.org/10.1002/jgc4.2011](https://doi.org/10.1002/jgc4.2011)  \n[wileyonlinelibrary.com/journal/jgc4](wileyonlinelibrary.com/journal/jgc4)  \n1 of 7  \ntesting is no longer family history dependent, and likely in the near future all patients with a solid tumor, particularly in advanced cancer, will be eligible for testing (Cobain et al. , 2021), which will expand the population impacted significantly over time. Therefore, many individuals with cancer are eligible for genetic counseling and testing to understand potential treatments, risk for futu","cbCaidxvi3bRCSmq","https://ap.wps.com/l/cbCaidxvi3bRCSmq","pdf",417372,"English","# Introduction\n# Methods\n## Data source and cohort selection\n# Results\n## Documentation of testing and family history\n# Discussion\n## Data limitations and standardization needs\n# Conclusion","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"The study aimed to understand the rates and factors associated with completion of cancer genetic testing among individuals with cancer using All of Us Research data.\"},{\"question\":\"How were eligible participants selected?\",\"answer\":\"Participants diagnosed with breast, ovarian, colon, endometrial, or pancreatic cancer were selected using the All of Us Workbench cohort builder tool.\"},{\"question\":\"What did the study find about documentation and test completion?\",\"answer\":\"Of 60,135 individuals with eligible cancer diagnostic codes, over 73% reported a family history of cancer, but only 281 had diagnosis or procedural codes for a cancer genetic test, and 82% completed the test after the cancer diagnosis.\"}]","Low frequency of structured documentation for cancer genetic testing in a large electronic health record dataset - A brief report using All of Us Research data | PDF",1790181893,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3270b6f14e59fa7b5a6d0bb7d0335f33.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67e2d83bbe2774be1bc469198ecb73f6.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e16e17ceed59105b3794f9fe331a811.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c7698b786d4806a2e01d4c9639c2db8.webp",980,1287]